GGrantIndex
Sort

78,016 grants matching breast cancer

Leadership Planning and Evaluation

$625,450
Ben H Park · Vanderbilt University Medical Center · P30 · FY2024 · CA

Leadership Planning and Evaluation

$625,450
Ben H Park · Vanderbilt University Medical Center · P30 · FY2022 · CA

Leadership Planning and Evaluation

$625,450
Jennifer A Pietenpol · Vanderbilt University Medical Center · P30 · FY2021 · CA

EPIDEMIOLOGY OF CANCER IN A COHORT OF OLDER WOMEN

$625,435
University Of Minnesota Twin Cities · R01 · FY2001 · CA

Pro & Anti-Inflammatory Cytokines in Colorectal Cancer

$625,384
Gloria Yf Ho · Albert Einstein College Of Medicine · R01 · FY2009 · CA

A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy

$625,359
Cohava Gelber · Serpin Pharma, Llc · R44 · FY2025 · CA

Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences

$625,343
Dennis E. Discher · University Of Pennsylvania · U01 · FY2025 · CA

Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)

$625,319
Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Leadership Planning and Evaluation

$625,311
Jennifer A Pietenpol · Vanderbilt University Medical Center · P30 · FY2020 · CA

Par-4 Regulation of Actomyosin Contractility as a Tumor Suppressive Mechanism in Breast Cancer

$625,273
James V Alvarez · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial

$625,257
Christine Rini · Northwestern University At Chicago · R01 · FY2025 · CA

Culturally Adapted Cognitive Behavioral Stress and Self-Management (CCBSM)

$625,257
Frank J Penedo · University Of Miami Coral Gables · R01 · FY2020 · CA

Consent in Genetic Research: An International Trial

$625,247
Case Western Reserve University · R01 · FY2005 · HG

SBIR Phase II: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo

$625,241
Charles A Testa · Echelon Biosciences, Inc. · · FY2011 · TIP

Developing DOSI Technology for Monitoring Response To Breast Cancer Chemotherapy

$625,224
Bruce J Tromberg · University Of California-Irvine · R01 · FY2010 · CA

Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis

$625,201
Gary D Luker · University Of Michigan At Ann Arbor · U01 · FY2021 · CA

Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy

$625,194
Richard Leo Wahl · Johns Hopkins University · U01 · FY2013 · CA

Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care

$625,180
Tina Hernandez-Boussard · Stanford University · R01 · FY2015 · CA

Targeting Neoantigens in Triple Negative Breast Cancer

$625,110
William E Gillanders · Washington University · R01 · FY2023 · CA

Targeting Neoantigens in Triple Negative Breast Cancer

$625,095
William E Gillanders · Washington University · R01 · FY2022 · CA

Breast Cancer and the Environment Research Program Coordinating Center

$625,067
Robert A Hiatt · University Of California, San Francisco · U01 · FY2014 · ES

Chemical tools for developmental biology

$625,036
James K Chen · Stanford University · R35 · FY2023 · GM

Chemical tools for developmental biology

$625,036
James K Chen · Stanford University · R35 · FY2024 · GM

Chemical tools for developmental biology

$625,036
James K Chen · Stanford University · R35 · FY2025 · GM

Computerized histologic image predictor of cancer outcome

$624,988
Anant Madabhushi · Case Western Reserve University · R01 · FY2017 · CA